Response_Letter_HTH-2019-93567.pdf
Response_Package_HTH-2019-93567.pdf
FOI Request - HTH-2019-93567 All Clinical Practice Review submissions and Drug Benefit Council recommendations and documents concerning Pharmacare's review of Xolair (omalizumab.) (Date Range for Record Search: From 01/01/2016 To 05/31/2019) FOI Request FOI Request 2020-03-24 Health 3 2020 Response_Letter_HTH-2019-93567.pdf Response_Package_HTH-2019-93567.pdf Interest Group $0.00